Categories: CancerNews

NYSE Content Advisory: Pre-Market Update + HPE Unveils Strategic Business Priorities

NEW YORK, Oct. 16, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on October 16th

  • Stocks are fractionally higher Thursday morning after the S&P 500 ended Wednesday in the green. NYSE-listed Bank of America and Morgan Stanley increased share price by over 4% following their latest earnings report.
  • NYSE-listed HPE rang the Opening Bell yesterday to celebrate its 10th anniversary and to highlight its 2025 HPE Securities Analyst Meeting. There, they discussed plans to boost shareholder value through stronger growth and returns.
  • Front Office Sports and DealMaker are hosting the first ever Asset Class event at the NYSE today. It will include panels on ownership and discussions about the new era of sports investing.


Opening Bell

Susan G. Komen celebrates National Breast Cancer Awareness Month, honoring patients and survivors across the country.


Closing Bell


Front Office Sports celebrates its inaugural Asset Class event presented by DealMaker.


Click here to download the NYSE TV App

View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update–hpe-unveils-strategic-business-priorities-302586305.html

SOURCE New York Stock Exchange

Staff

Recent Posts

TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering

Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication…

2 hours ago

More Than a Meal Plan: The Clinical Impact of a Kidney Dietitian

NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…

4 hours ago

President Trump’s Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else

"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…

4 hours ago

From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream

WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…

7 hours ago

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

10 hours ago